Our mission is to lengthen and improve the lives of the littlest heart patients by funding critical research and programs.
Congenital heart disease (CHD) is the #1 birth defect-related killer. Each year more children die from congenital heart defects than from all forms of pediatric cancer combined. There is no cure for any of the 40 types of defects, and little is known about what causes most of them.
Since its inception in 2003, Big Hearts to Little Hearts (BH2LH) has supported many projects including medicinal research, youth heart watch, single ventricle survivorship, treatment of CHD patients as they reach early adulthood, and the purchase of pulse oximeters to be sent home with CHD patients after surgery in order to detect issues before crisis.
Each year, BH2LH hosts several events including a gala, golf-outing, marathon, and walk-a-thon.